Schimmers, Nina http://orcid.org/0000-0001-7534-5845
Breeksema, Joost J.
Smith-Apeldoorn, Sanne Y.
Veraart, Jolien
van den Brink, Wim
Schoevers, Robert A.
Article History
Received: 8 July 2021
Accepted: 9 November 2021
First Online: 23 November 2021
Change Date: 17 June 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00213-023-06406-7
Declarations
:
: Ethic approval was not required for this systematic review of existing literature.
: NS, JB, SM, and WB have no conflicts of interest to declare. JV received a speakers fee from Janssen Pharmaceuticals, outside the submitted work. RS received research funding for two randomized clinical trials with generic oral esketamine from the Netherlands Organisation for Health Research and Development and the National Health Care Institute, a speakers fee from Janssen Pharmaceuticals, and consultancy fee from Clexio biosciences, both outside the submitted work.